Endpoints are predefined outcomes, like change in lung function or time to progression, that determine whether a clinical trial is judged successful. Because AI tools may propose or reprioritise endpoints, non‑specialist users need clarity that endpoint selection affects regulatory approval, statistical power and patient relevance, and cannot be changed casually based on algorithmic recommendations alone.